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        Monocytes, macrophages, and DCs form net-
works of phagocytic cells throughout most tis-
sues, the development of which are dependent 
on the CSF-1 receptor (csf1r, also known as 
CD115, c-fms, and M-CSF receptor) (  1, 2  ). 
These cells, which are sometimes referred to as 
the mononuclear phagocyte system, play major 
roles in development, scavenging, infl  ammation, 
and antipathogen defenses ( 3, 4 ). They are highly 
heterogeneous in phenotype, tissue distribution, 
and function (  3, 5, 6  ). Considerable attention is 
currently focused on the characterization of their 
progenitors and precursors, the signals driving 
their development in the BM, their migration to 
tissues, and their homeostasis in peripheral tis-
sues. CSF-1R and its two known ligands, M-CSF 
and IL34 (  7  ), are critical for the development of 
this lineage because M-CSF  –  defi  cient mice (op/
op and csf1      /     ) have a milder phenotype than 
the Csf1r-defi  cient mice (  8  ). Other cytokines, 
such as GM-CSF, FLT3, LT-    1    2 (LT-    ) 
(  9  –  15  ), and chemokines (  16, 17  ) have also been 
shown to control the development and homeo-
stasis of the macrophage and DC networks. 
  Cellular cloning and transplantation studies 
have shown that many macrophage subsets, most 
of the conventional DCs (cDCs) in the second-
ary lymphoid organs of mice, and at least a frac-
tion of the DCs in the mouse thymus probably 
originate from myeloid progenitors (  18  –  20  ). 
CORRESPONDENCE  
 Frederic  Geissmann: 
 frederic.geissmann@kcl.ac.uk
  Abbreviations used: cDC, con-
ventional DC; CDP, common 
DC precursor; GMP, granulo-
cyte-macrophage progenitors; 
iNOS, inductible nitric oxide 
synthase;   Lm  ,   Listeria monocyto-
genes  ; MDP, macrophage/DC 
precursor; PDC, plasmacytoid 
DC; PI, propidium iodide; ROI, 
reactive oxygen intermediate. 
    C. Auff  ray, D.K. Fogg, and E. Narni-Mancinelli contributed 
equally to this paper.   
  CX  3  CR1  +   CD115  +   CD135  +   common 
macrophage/DC precursors and the role 
of CX  3  CR1 in their response 
to infl  ammation 
    Cedric     Auff  ray  ,    1       Darin K.     Fogg  ,    1       Emilie     Narni-Mancinelli  ,    2     
  Brigitte     Senechal  ,    1       Celine     Trouillet  ,    1,3       Noah     Saederup  ,    4       Julia     Leemput  ,    5     
  Karine     Bigot  ,    5       Laura     Campisi  ,    2       Marc     Abitbol  ,    5       Thierry     Molina  ,    1     
  Israel     Charo  ,    4       David A.     Hume  ,    6       Ana     Cumano  ,    7       Gregoire     Lauvau  ,    2     
and   Frederic     Geissmann      1,3     
  1  Laboratory of Biology of the Mononuclear Phagocyte System, Institut National de la Sant  é   et de la Recherche M  é  dicale 
(INSERM) U838, Universit  é   Paris-Descartes, 75015 Paris, France 
  2  INSERM U924, Universit  é   de Nice-Sophia Antipolis, 06560 Valbonne, France 
  3  Centre for Infl  ammation Biology, Division of Immunity, Infection, and Infl  ammatory Diseases, King  ’  s College London, 
SE1 9RT London, England, UK 
  4  Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, San Francisco, CA 94158 
  5  Centre d  ’  etude et de recherche therapeutique en ophtalmologie, Universit  é   Paris-Descartes, 75015 Paris, France 
  6  The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, EH25 9PS Roslin, Scotland, UK 
  7  INSERM U668, Unit  é   de D  é  veloppement des Lymphocytes, Institut Pasteur, 75015 Paris, France     
  CX  3  CR1 expression is associated with the commitment of CSF-1R  +   myeloid precursors to 
the macrophage/dendritic cell (DC) lineage. However, the relationship of the CSF-1R  +   
CX  3  CR1  +   macrophage/DC precursor (MDP) with other DC precursors and the role of CX  3  CR1 
in macrophage and DC development remain unclear. We show that MDPs give rise to con-
ventional DCs (cDCs), plasmacytoid DCs (PDCs), and monocytes, including Gr1  +   infl  amma-
tory monocytes that differentiate into TipDCs during infection. CX  3  CR1 defi  ciency 
selectively impairs the recruitment of blood Gr1  +   monocytes in the spleen after transfer 
and during acute   Listeria monocytogenes   infection but does not affect the development of 
monocytes, cDCs, and PDCs. 
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macrophage/DC lineage. The MDP is also characterized by 
a low expression of CD117 (c-kit, the receptor for stem cell 
factor), as compared with GMPs and CMPs (  22  ), and expres-
sion of functional CSF-1R (CD115) and FLT3 (CD135) (  9, 
22  ). More recently, a precursor common to cDCs and PDCs 
(CDP) was reported and proposed to be distinct from the 
MDPs because the CDP gave rise to both cDCs and PDCs 
but not to monocytes/macrophages, whereas the MDPs give 
rise to cDCs and monocytes/macrophages but not to PDCs 
(  24, 25  ). We performed an analysis of mouse BM Lin        pre-
cursors by fl  ow cytometry (  Fig. 1 a  ), and the results indi-
cated that most CDPs expressed CX  3  CR1 at levels similar 
to its level of expression on MDPs, and that most MDPs 
expressed both CSF-1R/CD115 and CD135 at levels simi-
lar to their expression on CDPs (  Fig. 1  ).   These data confi  rm 
the data from Waskow et al. (  9  ) suggesting that MDPs and 
CDPs had an overlapping phenotype in the BM, and we 
therefore sought to reevaluate the diff  erentiation potential 
of MDPs. 
  MDPs give rise to monocytes, cDCs, and PDCs 
  Initial studies failed to identify PDCs in the progeny of MDPs 
after in vivo transfer into C57BL/6 mice (  9, 22, 23  ). However, 
PDCs in spleen express a CSF-1R-EGFP transgene (  2  ), and we 
observed that PDCs also expressed CX  3  CR1 (Fig. S1, avail-
able at http://www.jem.org/cgi/content/full/jem.20081385/
DC1) and that MDP gave rise to a population of CD11b        
CD11c  int   CX  3  CR1  +   splenocytes that are distinct from cDCs 
and monocyte/macrophages and may correspond to PDCs af-
ter in vivo transfer into irradiated hosts (Fig. S1). In addition, 
the availability of PDCA1 antibody now permits a better phe-
notypic defi  nition of PDC (  24, 25  ). We thus investigated the 
diff  erentiation potential in vivo of MDP, purifi  ed as previously 
described (Fig. S2) (  22  ), after i.v. adoptive transfer. BM MDP 
from CX  3  CR1  gfp/+   of the   Cd45.1/Cd45.2   genotypes was in-
jected i.v. into   Cd45.2  -irradiated hosts, and splenocytes were 
analyzed by fl  ow cytometry 6  –  7 d after transfer. Results indi-
cated that MDP gave rise to donor-derived PDCA1  +   CD11c  int   
CD11b        CX  3  CR1  +   PDC, as well as to CD11c  high   CD11b        
CX  3  CR1        and CD11c  high   CD11b  +   CX  3  CR1  +   cDC and to 
CD11b  +   CD11c        CX  3  CR1  +   monocytes (  Fig. 2, a  –  c  ).   As ex-
pected, the frequency of donor-derived PDCs and monocytes 
in the spleen was 2  –  3-fold lower than that of CD11b  +   and 
CD11b        cDCs (  Fig. 2 c  ). However, CD11b        PDCs were 
easily distinguishable from CD11b        cDCs by their expression 
of CX  3  CR1 and PDCA1 and their low expression of CD11c 
(  Fig. 2, a and b  ). MDP-derived CD11b  +   CD11c        monocytes 
expressed high levels of CX  3  CR1 (  Fig. 2 a  ), which unambigu-
ously distinguished them from granulocytes which do not ex-
press CX  3  CR1 (  29  ). 
  Because the anti-CD115 antibody (AFS98) used to purify 
CDP (  25  ), and MDP in one study (  9  ), was originally screened 
for its ability to block the binding of CSF-1 to its receptor 
(  26  –  28, 30, 31  ), we investigated whether labeling of MDPs 
with AFS98 would aff  ect the diff  erentiation of MDPs in our 
experimental model. We observed that, in vitro, the cloning 
Granulocyte-macrophage progenitors (GMPs [reference   21  ]) 
include a clonogenic BM macrophage/DC precursor (MDP) 
that gives rise to spleen cDCs (both the CD11c  +   CD8      +   
CD11b        and CD11c  +   CD8            CD11b  +   subsets) directly, with 
no monocytic intermediate, and to monocytes and macro-
phages (  9, 22, 23  ). The MDP has no signifi  cant granulocytic 
potential, and initial studies failed to detect a plasmacytoid DC 
(PDC) potential (  9, 22  ). Another precursor, common DC pre-
cursor (CDP), was recently shown to give rise to cDCs and 
PDCs but not to monocytes, and it did not respond to CSF-1 
(  24, 25  ). This result was interpreted as indicating the existence 
of two pathways for cDC generation. However, MDPs and 
CDPs are both included in the CD115  +   lin        fraction of BM 
progenitors (  9  ) and could represent diff  erent stages of diff  eren-
tiation along the same pathway. It is also possible that diff  er-
ences in diff  erentiation potential between these cells reported 
by diff  erent groups may refl  ect diff  erences in experimental pro-
tocols rather than intrinsic properties of the cells. 
  The chemokine receptor and adhesion molecule CX  3  CR1 
is not expressed on early hematopoietic progenitors and is fi  rst 
detected on MDPs. CX  3  CR1 is therefore associated with the 
commitment of myeloid progenitors to the monocyte/macro-
phage/DC lineage (  22  ). However, its role in the development 
and homeostasis of cells of the mononuclear phagocyte system 
remains unknown. 
  In this paper, we therefore reevaluated the diff  erentiation 
potential of the MDP and the possible roles of CX  3  CR1 in 
the diff  erentiation of mononuclear phagocytes in mice using 
adoptive transfer and disease models. We found that MDPs 
can give rise to PDCs, as well as to cDCs and monocytes, after 
adoptive transfer and that MDPs and CDPs share a similar 
surface phenotype (Lin        IL7Ra        CD117  int   CD135  +   CD115  +   
CX  3  CR1  +  ). The use of AFS98, an antibody designed to block 
CSF-1 binding to its receptor CD115, and CSF-1  –  dependent 
proliferation (  26  –  28  ) to purify MDP did not impair the ability 
of MDP to give rise to monocytes, cDCs, or PDCs in vivo. 
Because MDP can give rise to PDCs, cDCs, and monocytes/
macrophages, whereas CDP only give rise to PDCs and cDCs 
(  24, 25  ), MDP appears to exhibit a broader diff  erentiation 
potential than CDP and may represent an earlier precursor. 
CX  3  CR1 defi  ciency decreased the recruitment into the spleen 
of CD115  +   Gr1  +   monocytes (TipDC precursors) after irradia-
tion and during acute   Listeria monocytogenes   infection and de-
creased the effi   ciency of bacterial clearance but did not aff  ect 
the development of cDCs or PDCs. The results from this 
study, therefore, clarify the family tree of mononuclear phago-
cytes and uncover the role of CX  3  CR1 in Gr1  +   monocyte re-
cruitment to the spleen during infl  ammation and infection. 
    RESULTS   
  MDPs and CDPs are phenotypically overlapping cell 
populations in mouse BM 
  Expression of the chemokine receptor CX  3  CR1 in GMPs 
(Lineage        CD117  +   Sca1        IL7R            CD34  +   CD16/32  +   BM 
cells) (  21  ) characterizes the MDP (  22  ) and is thus associated 
with the commitment of myeloid progenitors toward the JEM VOL. 206, March 16, 2009 
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ent (  Fig. 3 b  ). When both donor mice were of the   Cx  3  cr1  +/        
genotype,   CD45.2   and   CD45.2/CD45.1   MDPs contributed 
equally to cDCs, PDCs, and CD11b  +   CD11c        monocytes 
(  Fig. 3, b and c  ). When   CD45.2 MDPS   were of the   Cx  3  cr1      /        
genotype and   CD45.2/CD45.1   MDPs were of the   Cx  3  cr1  +/        
genotype, they contributed equally to spleen DCs and PDCs 
(  Fig. 3, b and d  ). However, CX  3  CR1-defi  cient MDP gen-
erated spleen CD11b  +   CD11c        cells with an effi   ciency of 
one fi  fth to one tenth that of the control (  Fig. 3, b and d  ). 
MDP-derived CD11b  +   CD11c        splenocytes were negative 
for NK1.1, CD3, CD19, and Ly6G and expressed high lev-
els of CX  3  CR1 and intermediate levels of F4/80, and most 
of these cells expressed Gr1 (  Fig. 3 e  ). These characteristics 
are similar to those of CD115  +   Gr1  +   blood monocytes (  29  ) 
and of spleen monocytes, as recently described by Nahrendorf 
et al. (  32  ). Thus, we concluded that CX  3  CR1 may be se-
lectively involved in the development, recruitment, prolif-
eration, and/or survival of CD11b  +   CD11c        monocytes in 
the spleen. 
  CX  3  CR1 is important for the recruitment of blood 
Gr1  +   monocytes to the spleen during infection 
and for the clearance of   Lm   in mice 
  The only known ligand of CX  3  CR1 is the transmembrane che-
mokine fractalkine/CX  3  CL1, which is expressed in neurons, 
endothelial cells, and DCs (  33  –  37  ). CX  3  CR1 is involved in 
the adhesion of leukocytes, including monocytes in particular, 
to endothelial cells (  38  –  42  ) and in the migration of microglial 
cells (  43  ). Fractalkine is expressed in the T cell areas of lymph 
nodes (  37  ). PCR and in situ hybridization experiments indi-
cated that   CX      3     CL1   was also expressed in the spleen (  Fig. 4, 
a and b  ; and Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20081385/DC1).   Spleen   CX      3     CL1  -produc-
ing cells were located at the periphery of the B cell follicle, 
effi   ciency of single MDP seeded into 96-well plates in the 
presence of CSF-1, as well as the size of colonies, was re-
duced when AFS98 was added to the antibody cocktail 
used for cell sorting (Fig. S3, available at http://www.jem
.org/cgi/content/full/jem.20081385/DC1). However, ad-
dition of AFS98 to the antibody cocktail used for cell sort-
ing did not aff  ect the diff  erentiation potential of MDP in 
vivo (  Fig. 2 c  ). 
  These data indicate that MDP and CDP share expression 
of CX  3  CR1, CD115, and FLT3 and have an otherwise over-
lapping phenotype in the BM, whereas MDP appears to have 
a broader diff  erentiation potential than CDP after adoptive 
transfer in vivo because MDP gave rise to both DCs (PDCs 
and cDCs) and monocyte/macrophages. It is of note that ad-
dition of AFS98 to the antibody cocktail used for cell sorting 
decreased the proliferative response of MDP to CSF-1 in vi-
tro but did not aff  ect their diff  erentiation in to DCs or mono-
cytes in vivo. 
  CX  3  CR1-defi  cient MDPs have a decreased potential to give 
rise to spleen monocytes 
  Because expression of CX  3  CR1 is associated with the com-
mitment of myeloid progenitors to the monocyte/macro-
phage/DC lineage, we investigated the role of CX  3  CR1 in 
the homeostasis of this lineage. The number of MDPs in the 
BM was not aff  ected by CX  3  CR1 defi  ciency (  Fig. 3 a  ) and, 
on average, 6.5   ×   10  4   MDPs were recovered per femur from 
  Cx  3  cr1  +/        and   Cx  3  cr1      /        mice, suggesting that CX  3  CR1 is 
dispensable for MDP development in the BM.   We thus 
investigated the role of CX  3  CR1 in DC and monocyte de-
velopment from MDP by studying the fate of MDP in com-
petitive adoptive transfer, in which 10  4   MDP from each of 
two diff   erent donors of the   Cd45.2   and   Cd45.2/Cd45.1   
genotype were coinjected i.v. into a   Cd45.1   congenic recipi-
    Figure 1.         MDP and CDP share a similar phenotype.   BM cells from   Cx  3 cr1  gfp/+   reporter mice were labeled with antibodies against lineage markers 
(CD11c, CD11b, NK1.1, CD3, Ter119, CD19, and Gr1), ckit (CD117), FLT3 (CD135), and CSF-1-R (CD115) and analyzed by FACS. CDP and MDP are overlapping 
populations; lineage        CD117 low   CD135 +   CD115 +   cells (CDP) express CX  3  CR1 (gfp), whereas CD117  int   CX 3 CR1  CD115 +   cells (MDP) express CD135. Results are 
representative  of   > 10  experiments.   598 DIFFERENTIATION POTENTIAL OF MDP   | Auffray et al. 
defi  cient BALB/c mice, the number of monocytes was 
increased in the blood, whereas the number of monocytes 
in the spleen was decreased in comparison with controls 
(  Fig. 4 d  ). A similar phenomenon was observed in C57BL/6 
mice (  Fig. 5, e and f  ) both for high (3   ×   10  5     Lm  ;   Fig. 4 e  ) 
and low (7   ×   10  3     Lm  ;   Fig. 5 f  ) numbers of bacteria.   To in-
vestigate whether the proliferation of blood monocytes 
in the spleen of   Lm  -infected mice was involved in their 
accumulation in the spleen, monocytes from the BM 
and spleen of infected mice at 16 and 48 h after infection 
were isolated by fl  ow cytometry and analyzed for DNA 
content using propidium iodide (PI) staining (  Fig. 4 g   and 
Fig. S5, available at http://www.jem.org/cgi/content/full/jem
.20081385/DC1). Results indicated that BM monocytes, 
but not spleen monocytes, actively proliferate at 16 and 48 h 
which correspond to the marginal zone/T cell area (  Fig. 4, 
a and b  ). The precise identifi  cation of   CX      3     CL1  -expressing 
cells in the spleen will require the availability of specifi  c 
antibodies; however, localization of     C  x  3  cl1   messenger RNA 
is compatible with the expression of CX  3  CL1 in the mar-
ginal zone/T cell area of the spleen and, thus, with a role of 
  CX      3     CL1   in the recruitment of blood monocytes. 
  We tested the role of CX  3  CR1 for the recruitment of 
monocytes in the spleen by adoptive transfer of monocytes 
and during infection with   Lm  . Short-term competitive trans-
fer of BM monocytes from donors of   Cd45.2   and   Cd45.2/
Cd45.1   genotype into irradiated   Cd45.1   congenic recipi-
ents indicated that CX  3  CR1-defi  cient monocytes were only 
one tenth as effi   cient as control monocytes at accumulating 
in the spleen (  Fig. 4 c  ). During   Lm   infection in CX  3  CR1-
    Figure 2.         Differentiation potential of MDP in vivo.   (a – c)  MDPs  from   Cd45.1/2   or   Cd45.2 Cx  3 cr1  gfp/+   reporter mice were purifi  ed as described in Fig. S2 
(available at http://www.jem.org/cgi/content/full/jem.20081385/DC1) and were adoptively transferred into irradiated (900 rad) C57BL/6   Cd45.2   con-
genic recipients. Spleens of recipient mice were analyzed at day 7 after transfer by fl  ow cytometry, using lineage marker (NK1.1 CD3 CD19), CD11b, CD11c, 
and CD8-     antibodies. R1 corresponds to PDCs (Lin        CD11c int   CD11b       CX 3 CR1 +   cells), R2 and R3 correspond to cDCs (lin        CD11c high   CD11b       CX 3 CR1       cells 
and lin        CD11c high   CD11b +   CX 3 CR1 +   cells), and R4 corresponds to monocytes (lin        CD11b +   CD11c       CX 3 CR1 +   cells). The experiment was repeated fi  ve times 
with two to three mice per group and with similar results. (b) Donor-derived Lin        CD11c int   CD11b       CX 3 CR1 +   cells express PDCA1. (c) Role of anti-CD115 Ab. 
The number of donor-derived cells per spleen are represented after adoptive transfer of MDP, purifi  ed with or without CD115 antibody (  n   = at least 3 
mice per group from two experiments). Error bars show SD. (d) The fl  ow diagram represent the Lin        CD117 int   CD115 +   CD135 +   CX 3 CR1 +   MDPs that give rise 
to monocytes, cDCs, and PDCs and their putative relationship with other myeloid precursors.     JEM VOL. 206, March 16, 2009 
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  CD115  +   Gr1  +   monocytes recruited to the spleen 
during   Lm   infection differentiate into effector cells 
(TipDCs) that produce TNF, inductible nitric oxide synthase 
(iNOS), and reactive oxygen intermediates (ROIs) 
  Because the decreased recruitment of monocytes in the spleen 
during   Lm   infection in CX  3  CR1-defi  cient mice correlated 
with a decreased bacterial clearance, we investigated whether 
monocytes recruited to the spleen may be involved in the 
control of   Lm   growth and express eff  ector activities important 
for   Lm   clearance such as TNF-     secretion, iNOS expression, 
and reactive oxygen production. Monocytes have already 
been proposed to be precursors of TipDCs that accumulate 
to the spleen of mice infected with   Lm  , produce TNF-     and 
iNOS, and are needed for the control of primary infection 
(  44  –  46  ). Recruited monocytes were the majority (90%) of 
the CD115  +   Gr1  +   subset (Fig. S7, available at http://www
.jem.org/cgi/content/full/jem.20081385/DC1). In spleen, 
lineage        (Ly6G, NK1.1, CD3, and CD19) CD11b  +   CD11c        
splenocytes were identifi  ed as monocytes based on their ex-
pression of CD115, Ly6C/Gr1, and F4/80 (  Fig. 5 a  ) (  32  ). 
We observed that these spleen CD115  +   Gr1  +   monocytes 
produced TNF-    , iNOS, and ROI in mice during infection 
after infection and, thus, that accumulation of spleen mono-
cytes during infection is not a result of their proliferation in 
the spleen. In addition, the proportion of splenic monocytes 
that bind annexin-V in   Lm  -infected mice was similar in 
CX  3  CR1-defi  cient animals and in controls (Fig. S6), indi-
cating that the apoptosis rate of CX  3  CR1-defi  cient Gr1  +   
monocytes during   Lm   infection was not increased in com-
parison with controls. 
  Early control of   Lm   growth in the spleen was also signifi  -
cantly less effi   cient in CX  3  CR1-defi  cient mice on both BALB/c 
and C57BL/6 backgrounds (  Fig. 4, h and i  ). Bacterial load in 
the spleen 24 h after an i.v. infection was 4  ×   higher in BALB/c 
  Cx  3  cr1      /        mice in comparison with controls (  Fig. 5 h  ) and at 
least twice as high in C57BL/6 (  Fig. 4 i  ). 
  Altogether, these data indicate that CX  3  CR1 is important 
for the recruitment of monocytes to the spleen in irradiated 
host and during   Lm   infection, and for the early control of 
bacteria growth. It is of note that the frequency of monocytes 
in the spleen of noninfected mice were not aff  ected by 
CX  3  CR1 defi  ciency (  Fig. 4 d  ), indicating that CX  3  CR1 is 
dispensable for the recruitment of monocytes in the spleen in 
the steady state but important during acute infl  ammation. 
    Figure 3.         CX  3  CR1 is important for the development of CD11b  +   CD11c        monocytes.   (a) MDP numbers in BM from CX  3 CR1 +/      (black)  and 
CX  3 CR1    /     (white) mice. Data are the mean   ±   SD of fi  ve mice per group. (b  –  d) Competitive adoptive transfer of MDP into irradiated host (900 rad). Equal 
numbers (10  4  ) of MDPs from   Cd45.1/2   mice (blue) and   Cd45.2/2   mice (red) were mixed and adoptively transferred into a   Cd45.1   congenic  recipient. 
Spleens of recipient mice were analyzed at day 7 after transfer by fl  ow cytometry, using lineage marker (NK1.1 CD3 CD19), CD11b, CD11c, and CD8-    
antibodies. (b and c) When both   Cd45.1/2   and   Cd45.2/2   donor mice were of the   Cx  3 cr1 +/      genotype, both donors contributed equally to NK1.1        CD3      
CD19        CD11c high   CD11b       (R1, cDC) and NK1.1        CD3       CD19       CD11c high   CD11b +   (R2, cDC), NK1.1        CD3       CD19       CD11c int   CD11b       (R3, PDC), and NK1.1       
CD3        CD19       CD11b +   CD11c       splenocytes (R4). (b and d) In contrast, when   Cd45.1/2   donor mice were of the   Cx  3 cr1 +/      genotype and   Cd45.2/2   donor  mice 
were of the   Cx  3 cr1   /      genotype  (CX 3 CR1  defi  cient), both donors contributed equally to CD11c  +   cDCs in R1 and R2 but   CD45.1/2     Cx  3 cr1   +/       MDP s  were  10 ×  
more effi  cient than   CD45.2/2 CX     3   CR1- defi  cient   MDP  s in generating CD11b  +   CD11c       splenocytes in R3. Results in b are from one representative experi-
ment out of three, with two to three mice per experimental group, and bar graphs in c and d represent the mean and SD from three independent experi-
ments. The asterisk indicates a signifi  cative difference between groups (P   <   0.05 using the Wilcoxon test).     600 DIFFERENTIATION POTENTIAL OF MDP   | Auffray et al. 
monocytes or decreased survival, proliferation, or diff  erentia-
tion of MDP. As indicated by   Fig. 4 g   and Fig. S6, CX  3  CR1-
defi  cient Gr1  +   monocytes did not exhibit increased apoptosis 
rate during   Lm   infection, and the proliferation of monocytes in 
the spleen is not responsible for their accumulation. Total 
blood monocyte counts (CD115  +   CD11b  +   NK1.1       ) and 
Gr1  +   monocyte counts performed in   Cx  3  cr1  +/+    ,   Cx  3  cr1  +/       , 
  Cx  3  cr1      /       ,   Cx  3  cl1  +/+    , and   Cx  3  cl1      /        mice did not show any 
diff  erence between CX  3  CR1-defi  cient or CX  3  CL1-defi  cient 
mice and control mice (Fig. S9, a  –  c), and the proportion of 
Gr1  +   blood monocytes that bind annexin-V in the steady state 
was also similar in CX  3  CR1-defi  cient animals and in controls 
(Fig. S9 d). However, there was a 20% decrease in the numbers 
with   Lm   (  Fig. 5, b  –  d  ; and Fig. S8) and were localized in the 
T cell area and in the perifollicular area of the spleen (  Fig. 5 e  ). 
Altogether, these data therefore indicate that MDPs give rise 
to blood CD115  +   Gr1  +   monocytes, which are recruited to the 
spleen during infection via a process that involves CX  3  CR1, 
and that these cells expressed eff  ector functions that are im-
portant for   Lm   elimination. 
  Gr1  +   monocyte survival and MDP survival and proliferation 
are normal in CX  3  CR1-defi  cient mice 
  Other mechanisms that might be responsible for the impaired 
accumulation of CX  3  CR1-defi  cient CD115  +   Gr1  +   monocytes 
in the spleen include decreased survival or proliferation of 
    Figure 4.         CX  3  CR1 is important for the recruitment of CD11b  +   CD11c        monocytes to the spleen during infection.   (a and b) Mouse fractalkine/
CX  3  CL1 transcripts are detected in spleen tissue sections from WT mice around B cells follicles in the marginal zone/T cell area. Bars: (a) 500   μ  m; 
(b) 200   μ  m. (c) Short-term adoptive transfer of BM monocytes into irradiated WT recipient mice. Equal numbers (2   ×   10  5  ) of BM monocytes from 
  Cx  3 cr1 +/    Cd45.1/2   mice (blue) and   Cx  3 cr1   /    Cd45.2/2   mice (red) were mixed and adoptively transferred into a   Cd45.1   congenic recipient. CX  3 CR1-
expressing CD45.1/2 Gr1  +   monocytes are recruited in the spleen of irradiated host 10  ×   more effi  ciently than CX  3 CR1-defi  cient monocytes. The experiment 
was performed three times with two to three mice per group with similar results. (d  –  f) Monocyte recruitment in the spleen of infected mice. (d) BALB/c 
Cx  3 cr1 +/      and Cx  3 cr1    /     mice (seven per group) were infected i.v. with live   Lm   (3   ×   10 5  ), and monocytes (CX  3 CR1       gfp +   CD11b +   Ly-6C +   Ly-6G     ,  CD19     , 
CD3       , and NK1.1       ) were enumerated after 24 h in the blood and spleen of infected and control uninfected mice. (e) C57BL/6 Cx  3 cr1 +/      and  Cx 3 cr1    /    
mice (seven per group) were injected with 7   ×   10  5    Lm  , and monocytes were enumerated after 24 h in the blood and spleen of infected mice. (f) C57BL/6 
Cx  3 cr1 +/      and Cx  3 cr1    /     mice (seven per group) were injected with 7   ×   10  3    Lm  , and monocytes were enumerated after 48 h in the spleen of infected mice. 
  Lm   growth in the spleen of infected mice is shown. The asterisks indicate a signifi  cative difference between groups (P   <   0.05). (g) Absence of proliferation 
of monocytes in the spleen of   Lm  -infected mice. BALB/c mice (  n   = 6 per group) were infected with 3   ×   10  3   bacteria, spleen and leg bones were harvested 
16 and 48 h later, and cells were processed as indicated in Fig. S5 (available at http://www.jem.org/cgi/content/full/jem.20081385/DC1). Data indicate the 
percentage of BM precursors and spleen monocytes in G0/G1 and in G2  +  S as analyzed by fl  ow cytometry after DNA labeling with PI. The experiment was 
performed three times with similar results. (h) BALB/c Cx  3 cr1 +/+   and  Cx 3 cr1    /     mice were infected i.v. with live   Lm   (3   ×   10 3  ). Data show the number of 
bacteria (mean   ±   SE) in the spleen 24 h after infection. (i) C57BL/6 Cx  3 cr1 +/+   and  Cx 3 cr1    /     mice were injected with 10  4    Lm  . Data show the number of 
bacteria (mean   ±   SE) in the spleen 24 h after infection. Circles represent individual mice.     JEM VOL. 206, March 16, 2009 
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cDCs and monocytes were no longer labeled (Fig. S10 d), in-
dicating they that had undergone multiple rounds of division. 
Together with results from the adoptive transfer experiments 
depicted in   Fig. 4  , these data indicate that CX  3  CR1 defi  ciency 
does not signifi  cantly aff  ect the proliferation and diff  erentia-
tion potential of MDP. 
    DISCUSSION   
  This study investigated the diff  erentiation potential of the 
CX  3  CR1  +   MDPs and the role of CX  3  CR1 in their develop-
ment. First, our data confi  rmed that CX  3  CR1 was associated 
with the commitment of myeloid progenitors to the mono-
cyte/macrophage/DC lineage. The recently described CDP 
(  24, 25  ) also expresses CX  3  CR1, CD115, and FLT3, and its 
phenotype was overlapping with the MDP (this study and 
of blood Gr1        monocytes in CX  3  CR1-defi  cient and CX  3  CL1-
defi  cient mice in comparison with controls (Fig. S9, a  –  c), and 
the frequency of apoptotic Gr1        monocytes was higher in 
  Cx  3  cl1      /        mice in comparison with WT mice (Fig. S9 d). 
  The clonogenic and proliferation potentials of MDPs were 
then studied in vitro in the presence or absence of CX  3  CL1/
fractalkine. CX  3  CR1/CX  3  CL1 did not confer any advantage 
in terms of growth or survival, even in competition with WT 
cells (Fig. S10, a  –  c, available at http://www.jem.org/cgi/
content/full/jem.20081385/DC1). The role of CX  3  CR1 in 
the proliferation of MDP-derived cells in vivo was investi-
gated by labeling MDP and CD19  +   B cells, as a control, with 
Cell Tracker 633 (BODIPY 630/650 MeBr) and carrying out 
the adoptive transfer of these cells into irradiated recipients. 
6 d later, 100% of both   Cx  3  cr1  +/        and   Cx  3  cr1      /        MDP-derived 
    Figure 5.         Functions of spleen CD115  +   Gr1  +  /TipDCs.   (a)  CD11b +   spleen cells from Cx  3 cr1 gfp/+   reporter mice negative for lineage marker (NK1.1, CD3, 
B220, CD19, and CD11c) were analyzed for Ly6G, Ly6C, F4/80, CD115, and   CX     3     CR1 (  gfp) expression by multicolor fl  ow cytometry. (b) TNF production by 
lineage        CD11c low   CD11b +   cells 24 h after i.v. infection with   Lm  . Gated cells (circled) are displayed in red. Data show representative FACS profi  les from 
three experiments. (c and d) Production of TNF-    , iNOS, and ROI by lineage        CD11c low   CD11b +   Gr1 + /Ly6C +   spleen cells from C57BL/6 mice 24 (c) and 48 h 
(d) after i.v. infection with 7   ×   10  5   bacteria and 7   ×   10  3   bacteria, respectively. The experiment was repeated fi  ve times with similar results. Error bars show 
SD. (e) iNOS  +   cells in the spleen of BALB/c mice 24 h after infection with 10  5   WT   Lm   (red) express CD11b and Ly6C and are found in the perifollicular area 
and T cell area. B cell follicles are labeled with anti-B220 antibodies (green) and T cells are labeled with anti-CD3 antibodies (blue). Bar, 100   μ  m. The ex-
periment was repeated fi  ve times with similar results.     602 DIFFERENTIATION POTENTIAL OF MDP   | Auffray et al. 
the endothelium for considerable periods of time without ex-
travasation (  42  ). Human CX  3  CR1  high   cells also adhere to the 
endothelium via a CX  3  CR1-dependent mechanism (  38  ), and 
adhesion is known to increase survival as has been shown for 
CX  3  CR1-expressing cells binding to CX  3  CL1 via a mecha-
nism involving an Akt/GSK-3      –  mediated antiapoptotic sig-
naling pathway (  48, 49  ). 
  The role of CX  3  CR1 for the recruitment of CD115  +   
Gr1  +   monocytes/TipDC precursors is reminiscent of the phe-
notype of CCR2-, MCP1-, and MCP3- defi  cient mice (  45, 
50  ). However, the disruption of the CCR2 axis results in a 
much more dramatic phenotype because both Gr1  +   mono-
cytes exit from the BM into the bloodstream, and the recruit-
ment into tissues of the few monocytes that exit the BM is 
impaired in these mice (  45, 46, 50  ). Thus CCR2-defi  cient 
mice have reduced numbers of TipDCs. In contrast, BM out-
put is intact in CX  3  CR1-defi  cient mice, the number of blood 
Gr1  +   monocytes are normal, and only their recruitment is im-
paired. Similarly, CCR2-defi  cient mice have a dramatically 
impaired innate response to   Lm   infection and die of infection 
within a few days (  46  ), whereas CX  3  CR1-defi  cient hosts ex-
hibit a reduced clearance of   Lm   at 24 h after infections (  Fig. 3  ), 
but at later time points we did not observe signifi  cant diff  er-
ences in the survival of CX  3  CR1-defi  cient and control mice 
(not depicted). We therefore propose that CX  3  CR1 may play 
an important role in mediating the recruitment of CD115  +   
Gr1  +   infl  ammatory monocytes in the white pulp of the spleen 
during acute infl  ammation, possibly through adhesion to the 
capillary endothelial cells of the marginal zone of the spleen. 
    MATERIALS AND METHOD  S 
  Animals.     C57BL/6 mice on   Cd45.2   or   Cd45.1   congenic backgrounds were 
obtained from Charles River Laboratories.   Cx  3  cr1    gfp   reporter mice on the 
C57BL/6 and BALB/c background were obtained from D. Littman  ’  s laboratory 
(Skirball Institute, New York, NY).   Cx  3  cr1  gfp/gfp     C57BL/6 mice were crossed 
with WT   Cd45.1   mice to produce   Cx  3  cr1  gfp/+     mice on a mixed   Cd45.1/Cd45.2   
background for competitive adoptive transfer experiments. C57BL/6   Cx  3  cr1  +/+    ,   
Cx  3  cr1  gfp/+    , and   Cx  3  cr1  gfp/gfp     and BALB/c   Cx  3  cr1  +/+     and   Cx  3  cr1  gfp/gfp     were bred 
and maintained in the specifi  c pathogen-free animal facility of the Institut 
F  é  d  é  ratif de Recherche (IRF) Necker-Enfants Malades and of the Institut Na-
tional de la Sant  é   et de la Recherche M  é  dicale U924. C57BL/6   Cx  3  cl1  +/+     and 
  Cx  3  cl1      /        and ApoE      /        Cx  3  cl1  +/+     and   Cx  3  cl1      /        mice were maintained in the 
laboratory of I.F. Charo (Gladstone Institute of Cardiovascular Disease, Univer-
sity of California, San Francisco, San Francisco, CA). All mice were maintained 
according to institutional guidelines and used at the age of 8  –  14 wk old. 4-wk-
old C57BL/6 mice on the   Cd45.1   background were used as adoptive transfer 
recipients. Experimental protocols using mice were examined and approved by 
the Direction Departementale des Services V  é  t  é  rinaires de Paris (Paris, France). 
  Antibodies and recombinant proteins.     The following purifi  ed or conju-
gated antibodies were purchased from BD: purifi  ed  anti-Fc    RIII/II 
(CD32/16, clone 2.4G2); PE-, APC-, PcP-, or biotin-labeled anti-CD11b 
(M1/70); PE-, APC-, or biotin-labeled anti-CD117 (cKit; 2B8); PE- or 
APC-labeled anti-NK1.1 (PK136); FITC-, PE-, or APC-labeled anti-CD11c 
(HL3); PE- or APC-labeled anti  –  TCR-     (H57-597); PE- or APC-labeled 
anti-B220 (RA3-6B2); biotin-labeled anti-CD45.2 (104); FITC- or biotin-
labeled anti-Ly6C (AL-21); PE-labeled anti-Ly6G (1A8); PE-Cy7  –  labeled 
anti  –  CD8-     (53  –  6.7); PerCP-labeled anti-CD4 (RM4-5); PE-labeled anti-
CD3 (145-2C11); PE-labeled anti-CD19 (MB19-1); APC-labeled anti  –
  TNF-     (MP6-XT22); and control rat IgG  1   mAb. The following antibodies 
were purchased from eBioscience: PE-Cy7  –  labeled anti-CD45.1 (A20), 
reference   9  ). MDP can give rise to both DCs (PDCs and 
cDCs) and monocytes/macrophages but do not have the po-
tential to give rise to granulocytes. Thus, they have a more 
restricted diff  erentiation potential than CMPs, which can 
give rise to all myeloid cells, and GMPs, which can give rise 
to granulocytes, macrophages, and DCs (  Fig. 2 d  ). CDP has 
been reported to give rise to cDCs and PDCs but not macro-
phages and, thus, has a more restricted diff  erentiation poten-
tial than MDPs and may be placed downstream (  Fig. 2 d  ). 
Further studies will be needed to investigate the develop-
mental relationship between MDPs and CDPs. 
  CX  3  CR1 is a later marker than CSF-1R in myeloid lin-
eage commitment. In this study, we investigated the role of 
CX  3  CR1/CX  3  CL1 in the development of MDP-derived cells 
by studying mice lacking CX  3  CR1 or its ligand CX  3  CL1/frac-
talkine during acute and chronic infl  ammation and in a sensi-
tive competitive adoptive transfer model. This study revealed 
an important role of CX  3  CR1 in the recruitment of CD115  +   
Gr1  +   infl  ammatory monocytes, which are immediate precur-
sors to TipDCs, to the spleen during infection and for the con-
trol of bacterial growth during primary infection in two 
diff  erent strains of mice (C57BL/6 and BALB/c). 
  Impaired recruitment of CX  3  CR1-defi  cient Gr1  +   mono-
cytes/TipDCs is the most likely mechanism underlying our 
observations for the following reasons: in situ hybridization ex-
periments (  Fig. 4   and Fig. S4) indicated that fractalkine is ex-
pressed in the marginal zone/T cell areas of the spleen, where 
TipDC accumulate during infection (  Fig. 5  ) (  44  ); short-term 
adoptive transfer of BM monocytes into irradiated hosts de-
creased the accumulation of CX  3  CR1-defi  cient monocytes in 
the spleen by a factor of ten (see   Fig. 4  ); during acute   Lm   infec-
tion, the number of monocytes was higher in the blood of in-
fected CX  3  CR1-defi  cient mice but decreased in the spleen 
(  Fig. 4  ), and the frequency of annexin-V  high   monocytes was not 
increased in spleen from infected CX  3  CR1-defi  cient  mice 
(Fig. S6); CX  3  CR1 defi  ciency does not appear to infl  uence the 
survival of CD115  +   Gr1  +   monocytes in the periphery (Fig. S9); 
and fi  nally, we have found that CX  3  CR1 was redundant for 
MDP development, survival, homing to the spleen, and diff  er-
entiation in vivo and in vitro (Fig. S10) and MDP-derived 
spleen cDCs and PDCs appear to develop normally. 
  It is of note that although CD115  +   Gr1  +   (CX  3  CR1  low  ) in-
fl  ammatory monocytes were present in normal numbers in 
both CX  3  CR1- and CX  3  CL1-defi  cient mice, the present data 
confi  rm that CX  3  CR1 defi  ciency also slightly decreases the 
survival of the CD115  +   Gr1        monocytes (Fig. S9). This result 
was expected and consistent with the conclusions that we 
made from our earlier adoptive transfer experiments (  29  ) and 
with a more recent study (  47  ). CX  3  CR1 has been previously 
shown to be important for the adhesion of CD115  +   Gr1        
(CX  3  CR1  high  ) monocytes to the endothelium of blood vessels 
(  38, 42  ). The mechanism underlying the selective survival de-
fect of CD115  +   Gr1        CX  3  CR1  high   monocytes may thus be 
related to the unique patrolling behavior of these cells, which 
attach themselves to the luminal side of the endothelium via a 
CX  3  CR1- and LFA1-dependent mechanism, crawling onto JEM VOL. 206, March 16, 2009 
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with collagenase   d  , homogenized, and fi  ltered. Erythrocytes were lysed using 
red blood cell lysis buff  er for quantifi  cation of cell populations in reporter 
mice or were depleted by density gradient centrifugation (LSM 1077; Euro-
bio) for analysis of adoptive transfer recipients. PBMC or splenic mono-
nuclear cell suspensions were enumerated with a Guava Viacount analyser. 
Fc receptors were blocked, and then cells were labeled using fl  uorochrome- 
or biotin- conjugated antibodies and analyzed by fi  ve, six, or seven-color fl  ow 
cytometry using a Cyan ADP. 
  For in vivo proliferation assays, splenocytes or FACS-sorted MDP 
were labeled using BODIPY far-red cell tracker (Invitrogen), transferred to 
congenic recipients, and analyzed by fl  ow cytometry after 5 d. Cell divi-
sion of MDP-derived cells was assessed by comparison with nondividing 
B220  +   B lymphocytes. 
  In vitro analysis of cell survival, proliferation, and diff  erentiation 
potential.     MDPs from C  x  3  cr1    +/      or C  x  3  cr1        /      were purifi  ed by FACS, as 
described in the previous section, and plated at one cell per well into 96-well 
plates containing Opti-MEM (Invitrogen) supplemented with 10% FCS (PAN 
biotech), 100 U/ml penicillin, and 100   μ  g/ml streptomycin (Invitrogen) along 
with CSF-1, GM-CSF, or both (10 ng/ml each unless otherwise indicated) in 
the presence or absence of recombinant CX  3  CL1. Resulting colonies were 
enumerated after incubation at 37  °  C in 5% CO  2   for 7 d. For diff  erentiation 
analysis, colonies were recovered from wells by vigorous pipetting and were 
immunolabeled for cell surface markers as described in the previous section. 
For determination of proliferation potential, individual cells from colonies aris-
ing from single cell clones were counted using a 10 or 5  ×   objective on a 
microscope (Axiovert; Carl Zeiss, Inc.). Counting accuracy was validated 
by digital analysis of random colonies of various sizes photographed using a 
camera (CoolSnap ES; Roper Scientifi  c) and Photoshop CS (Adobe) for 
marking of individual cell bodies. 
  For analysis of proliferation under competitive conditions, 100 MDPs each 
from C  x  3  cr1    +/      and   Cx  3  cr1      /        mice on diff  erent CD45 congenic backgrounds, 
as described in the Animals section, were deposited into wells of 96-well round-
bottom plates, coated with fractalkine or BSA as control, and grown in decreas-
ing concentrations of CSF-1. After 5 d in culture, cells were harvested from 
individual wells and analyzed for origin by CD45.1 and CD45.2 staining by fl  ow 
cytometry. At least 10 wells were analyzed per experiment. 
    Lm   infection.     The   Lm   10403s WT strain was used in these experiments. This 
strain exhibit an LD  50   of 7   ×   10  4   in C57BL/6 mice. Bacteria were prepared 
from clones grown from organs of infected mice. Stocks of bacteria were kept 
frozen at     80  °  C. For infections, bacteria were grown to a logarithmic phase 
(OD  600   = 0.05  –  0.15) in Broth Heart Infusion medium (Sigma-Aldrich), di-
luted in PBS, and injected i.v. into lateral tail vein with 0.1  –  10  ×   LD  50   of WT 
  Lm   per mouse. To study production of TNF and iNOS, organs were cut in 
small pieces and incubated at 37  °  C for 20 min in HBSS medium (Invitrogen) 
containing 4,000 U/ml collagenase I (Invitrogen) and 0.1 mg/ml DNase I 
(Roche). Red blood cells were lysed for 2  –  3 min in 170 mM NH  4  Cl and 
17 mM Tris HCl, pH 7.4. Cells were stained with the specifi  ed antibodies in 
100 ml PBS containing 0.5% of BSA (FACS buff  er). For the TNF-     intracel-
lular staining, splenocytes were incubated at 37  °  C and 5% CO  2   for 3  –  4 h in 
RPMI 1640 (Invitrogen) containing 5% FCS and 2 mg/ml Golgi Plug (BD) 
with or without 5   ×   10  8   HKLM/ml. Cells were incubated for 20 min on ice 
with the indicated cell surface marker mAbs, fi  xed in 1% PFA FACS buff  er for 
20 min on ice, and permeabilized for 30 min in Perm/Wash (BD). For intra-
cellular staining of TNF-    , cells were incubated for 20 min on ice in FACS 
buff  er containing anti  –  TNF-     or control rat IgG  1  . For intracellular staining of 
iNOS, cells were incubated for 20 min on ice in FACS buff  er containing anti-
iNOS rabbit polyclonal or control normal goat IgG, and staining was revealed 
using goat anti  –  rabbit Alexa Fluor 647 mAb. In all cases, cells were washed, 
fi  xed for 30 min in 1% PFA FACS buff  er, and analyzed on a FACSCalibur cy-
tofl  uorometer (BD). To study the production of ROI, 5  –  10   ×   10  6   splenocytes 
were incubated for 3 h at 37  °  C and 5% CO2 in 5% FCS RPMI 1640 with 
5   ×   10  8   HKLM/ml and 160   μ  M hydroethidine. Hydroethidine is oxidized by 
ROI in red fl  uorescent ethidium bromure, therefore allowing for the detection 
APC  –  Alexa Fluor 750-labeled anti-CD45.2 (104), PE- or PE-Cy5  –  labeled 
anti-Flt3 (A2F10), and PE- or biotin-labeled anti CD115 (AFS98). Anti-
CD169 (MOMA-1) and APC- or biotin-labeled F4/80 clone Cl:A3-1 were 
purchased from AbD Serotec. mPDCA1 antibody was purchased from Milt-
enyi Biotec. Anti  –  NOS-2 (M-19) polyclonal rabbit was purchased from Santa 
Cruz Biotechnology, Inc. Goat anti  –  rabbit Alexa Fluor 647 was purchased 
from Invitrogen. Hydroethidine was purchased from Polysciences, Inc. Anti-
bodies used for depletion, including TER-119 (erythrocytes), RB6-8C5 
(Ly6-C/G), and GK1.5 (CD4), were supernatants of hybridomas donated by 
B. Rocha (IFR Necker, Paris, France). Streptavidin Pacifi  c Blue was pur-
chased from Invitrogen. Dead cells were gated out by PI labeling (Invitrogen). 
APC-labeled annexin V was purchased from BD. Recombinant mouse mac-
rophage CSF-1 and recombinant mouse fractalkine (CX  3  CL1) were pur-
chased from R  &  D Systems. Recombinant mouse GM-CSF was purchased 
from PeproTech. 
  Mouse blood phenotyping.     Blood was drawn according to institutional 
guidelines, and red blood cells were lysed in 5 vol of red blood cell lysis buf-
fer (155 mM NH  4  Cl, 10 mM NaHCO  3  , and 0.1 mM EDTA). Cell suspen-
sions were fi  ltered using a 40-  μ  m fi  lter (BD), washed twice in PBS 0.5% 
BSA, and an aliquot was counted with a Guava ViaCount analyzer (Guava 
Technologies). Cells were incubated with anti  –  mouse FcRII/III (2.4G2) for 
10 min at 4  °  C in PBS 0.5% BSA and then stained with anti  –  mouse antibod-
ies specifi  c for CD11b (PE-Cy7), Ly6C (biotin), NK1.1 (APC), and CD115 
(PE). Biotinylated antibodies were revealed by subsequent staining with 
streptavidin  –  Pacifi  c blue. Cells were analyzed on a nine-color CYAN ADP 
fl  ow cytometer (Dako) using the Summit 4.3 software (Dako), and mono-
cytes were identifi  ed as CD115  +  , CD11b  +  , SSC  lo  , NK1.1       , or Ly6c  +or      
cells. Annexin V staining was performed according to the manufacturer  ’  s in-
structions. Absolute numbers were calculated using cell percentages and total 
white blood cells counts. Data on blood monocytes counts were obtained 
from littermate mice at the age of 7  –  8 wk for   Cx  3  cr1  +/+    ,   Cx  3  cr1  gfp/+    , and 
  Cx  3  cr1  gfp/gfp     mice and 13  –  14 wk old mice for   Cx  3  cl1  +/+     and   Cx  3  cl1      /        mice. 
  Phenotyping of splenocytes.     Spleens were removed, triturated in RPMI 
2% FCS at 4  °  C with the end of a 3-ml syringe, and then passed through a 
100-  μ  m cell strainer (BD) in one well of a 6-well plate. Cell suspensions 
were fi  ltered using a 40-  μ  m fi  lter, washed twice in PBS 0.5% BSA, blocked 
with anti  –  mouse FcRII/III, and then stained with anti  –  mouse antibodies 
specifi  c for CD3e, CD11c, CD19, Ly6G, CD11b, Ly6C, mPDCA1, NK1.1, 
and CD115. Biotinylated antibodies were revealed by subsequent staining 
with streptavidin  –  Pacifi  c blue. Annexin V staining was performed according 
to the manufacturer  ’  s instructions. Cells were analyzed on a CYAN ADP 
fl  ow cytometer using Summit 4.3 software (Dako). 
  Phenotyping, isolation, and adoptive transfer of MDP and CDP.     BM 
cells from femurs and tibias of Cx  3  cr1  gfp/+   mice aged 6 wk were fl  ushed with 
serum-free RPMI, Fc receptors were blocked with antibody to Fc    RIII/II 
(2.4G2), and cells were labeled using antibodies against lineage markers (IL7-
R    , CD11c, CD11b, NK1.1, CD3, Ter119, CD19, and Gr1), CD117, 
CD115, and CD135. For purifi  cation of MDP, red blood cells and Gr1-ex-
pressing cells were removed using Ter119 and RB68C5 antibodies as previ-
ously described (  22  ). MDP (defi  ned as IL7-R            lineage        gfp  +   [CX  3  CR1] 
CD117  int   expressing CD115; Fig. S2), CDP (defi  ned as IL7R            lineage        
CD135  +   CD115  +   CD117  int  ; Fig. S3), and BM monocytes (defi  ned as gfp  +   
CD11b  +   CD115  +   NK1.1        CD117       ) were purifi  ed by fl  ow cytometry using 
FACSVantage or FACSAria cell sorters (BD). For competitive adoptive trans-
fers, monocytes or MDP were purifi  ed from   Cx  3  cr1  gfp/gfp     mice on a   Cd45.2   
background and from   Cx  3  cr1  gfp/+     mice on a   Cd45.2/.1   background, unless 
otherwise indicated. FACS-purifi  ed cells from each genetic background were 
mixed at a 1:1 ratio and were transferred i.v. to 4-wk-old recipient mice on a 
  Cd45.1   background. Recipients were either irradiated with 10 Gy or were 
not irradiated. For analysis of cell populations in WT mice,   Cx  3  cr1  gfp     reporter 
mice, and adoptive transfer recipients, blood and organs were harvested from 
anaesthetized mice as described previously (  29  ), and spleens were digested 604 DIFFERENTIATION POTENTIAL OF MDP   | Auffray et al. 
graphic emulsion (NTB2; Eastman Kodak) for 2 mo at 4  °  C. Sections were 
developed, counterstained with toluidine blue (0.2% in 0.2 M sodium ace-
tate, pH 4.3), covered with a coverslip, and examined under bright- or dark-
fi  eld illumination with a light microscope (DNRB2; Leica). Both bright- and 
dark-fi  eld images were collected by a charge-coupled device camera (Nikon) 
connected to a computer. 
  Online supplemental material.     Fig. S1 shows the expression of CX  3  CR1 
by PDCs. Fig. S2 shows the sorting gates for MDPs. Fig. S3 shows the eff  ects 
of the AFS98 anti-CD115 antibody on the response of MDP to M-CSF in 
vitro. Fig. S4 shows the expression of CX  3  CL1 in the spleen. Fig. S5 shows 
analysis of the proliferation of monocytes in the spleen and BM. Figs. S6 and 
S7 show the ratio of Gr1  +   and Gr1        monocytes in the spleens of infected 
and control mice and the frequency of annexin-V  –  positive cells. Fig. S8 
describes the analysis of the production of TNF, NOS2, and ROI by Gr1  +   
monocytes in the spleen of infected and controls mice. Fig. S9 indicates 
the absolute numbers of Gr1  +   and Gr1        monocytes in the blood of mice 
defi  cient in CX  3  CR1 or CX  3  CL1 in comparison to controls. Fig. S10 de-
scribes the role of CXRCR1 in the proliferation of MDP in vitro and in vivo. 
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20081385/DC1. 
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